Important announcement for FreeStyle LibreLink app users.

Make sure your patients are running the latest FreeStyle LibreLink app – version 2.12.0. 
Having the latest app version is key to getting the best performance.

Learn More >

ADC-109376 v1.0

Now It's time to transition patients to The Libre 2 Plus Sensors

Libre 2 sensor will be phased out at the end of August 2025.
Find out what you need to do >

Expanding Access Case Studies

Enabling Equitable Access to Technology

Find out how local health authorities have addressed variations in access to glucose-sensing technology

CGM in Primary Care

Discover how initiating Continuous Glucose Monitoring (CGM) in primary care can help to improve patient health outcomes
 

Enabling Equitable Access to Technology

Increasing access to diabetes technology across North East and North Cumbria
 

Equity of Access: Driving positive change to increase access to glucose sensing technology across Scotland

CGM in Primary Care

A GP’s Perspective – Embracing CGM for people with Type 2 diabetes on multiple daily insulin injections
 

How Type 2 diabetes insulin users (including basal only, premixed insulin and basal/bolus regimes) are benefitting from technology
 

Implementing Continuous Glucose Monitoring (CGM) in Primary Care
 

Sandwell pioneers primary care implementation of diabetes tech to improve community wellbeing
 

West Yorkshire Integrated Care Board (ICB) expands primary care prescribing for diabetes technology
 

Contact the Market Access Team

As a registered Healthcare Professional by completing the form below an Abbott representative will contact you regarding your enquiry.

Please provide a valid first name.
Please enter a valid last name.
Please enter the email address.
The subject of your message must not contain special characters.
Please enter a message.

Required fields are indicated with an asterisk (*).

 ADC-88868 v5.0

Loading...